Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2562-2025Class II

Exactech Equinoxe, Reverse Shoulder Humeral Liners, 322-38-00 (145-DEG PE 38MM HUM LINER +0), REF: 322-38-03...

Exactech, Inc. / initiated 2025-08-15 / Open, Classified / root cause: manufacturing process

Exactech, Inc. began a recall of Exactech Equinoxe, Reverse Shoulder Humeral Liners, 322-38-00 (145-DEG PE 38MM HUM LINER +0), REF: 322-38-03 (145-DEG PE 38MM HUM LINER +2.5), REF:322-42-00... on . FDA classified it as Class II and gives the reason as "Reverse Shoulder humeral liners have an articular surface position outside of the dimensional specification within the labeling". As of , the recall status on record is Open, Classified, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-2562-2025
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Exactech, Inc.
Product
Exactech Equinoxe, Reverse Shoulder Humeral Liners, 322-38-00 (145-DEG PE 38MM HUM LINER +0), REF: 322-38-03 (145-DEG PE 38MM HUM LINER +2.5), REF:322-42-00 (145-DEG PE 42MM HUM LINER +0), REF: 322-42-03 (145-DEG PE 42MM HUM LINER +2.5)
Product code
PHX Shoulder Prosthesis, Reverse Configuration
Reason for recall
Reverse Shoulder humeral liners have an articular surface position outside of the dimensional specification within the labeling.
Root cause tag
manufacturing process
FDA root cause
Process design
Action
On August 15, 2025, Exactech, Inc. initiated a "Urgent Voluntary Medical Device Recall". Exactech asked consignees to take the following actions: 1. Healthcare providers who have treated patients using the Exactech Equinoxe Humeral Liners subject to this recall should continue to follow those patients pursuant to the healthcare provider s standard of care. 2. Do Not Use / Quarantine any of these products in your inventory. 3. Segregate and return unused units via prepaid packaging to Exactech. 4. Complete the Recall Confirmation Form confirming product return or on-hand inventory. 5. Transmission of this Recall Notice: This notice must be passed on to all who need to be aware within your organization and any locations the affected products has been transferred to. This recall has been reported to the U.S. FDA and will be reported to other regulatory authorities as required.
Quantity in commerce
11,542 units
Distribution
Worldwide - US Nationwide distribution in the states of CA, CO, FL, GA, HI, ID, IL, IN, KS, KY, LA, MA, MD, ME, MN, NV, NY, OH, OK, PR, SC, TN, TX, VA, WI and the countries of Australia, Austria, Brazil, Canada, Colombia, France, United Kingdom, Guatemala, India, Italy, Japan, Korea, Germany, The Netherlands, Slovenia, South Africa, Spain, Sweden, Switzerland, Thailand, Dubai.
Product codes and lots
All Serial Numbers, REF: 322-38-00/UDI:10885862593832, REF: 322-38-03/UDI:10885862593849, REF: 322-42-00/UDI: 10885862593917, REF:322-42-03/UDI:10885862593924

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2562-2025
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2561-2025Class IIOngoingVoluntary: Firm initiated
Z-2562-2025Class IIOngoingVoluntary: Firm initiated